Background and Purpose—
We hypothesized that technetium-99m-ethylene dicysteine-metronidazole (
99m
Tc-EC-MN) localizes to brain tissue that is hypoxic but viable. This study prospectively evaluated the relationship between neurological outcome and uptake of
99m
Tc-EC-MN in peri-infarcted regions of the brain.
Methods—
Eight patients with acute ischemic stroke in the territory of the left middle cerebral artery underwent
99m
Tc-EC-MN and
99m
Tc-ethyl cysteinate dimer (ECD) brain SPECTs on the same day during the subacute stage (10.3±2.5 days). The infarct volumes from
99m
Tc-ECD images (IV
ECD
), infarct volumes from diffusion-weighted MRI images (IV
DW
), and hypoxic volume (HV) from
99m
Tc-EC-MN images were calculated. The net infarct volume (NIV
ECD
) was defined as IV
ECD
minus HV. The National Institutes of Health Stroke Scale scores were measured on admission and days 1, 3, 7, and 30.
Results—
IV
ECD
was greater than IV
DW
. The lesion-to-normal count-density ratios of
99m
Tc-EC-MN ranged from 1.80 to 5.96. HV was 60.2±65.2 cm
3
, and the mean percent HV was 24.5±28.1% of IV
ECD
. NIV
ECD
was 162.6±133.4 cm
3
and was significantly smaller than IV
ECD
. NIV
ECD
was significantly correlated with National Institutes of Health Stroke Scale score at 1 month and was a significant predictor of neurological deficit at 1 month.
Conclusions—99m
Tc-EC-MN brain SPECT can detect hypoxic tissue after acute ischemic stroke and, in combination with
99m
Tc-ECD brain SPECT, is useful in predicting neurological outcome in ischemic stroke patients.